Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ISRCTN54091957) titled 'PuntoCare: Digital support platform for mild cognitive impairment (MCI) and dementia (v1.0)' on Sept. 18.
Study Type: Interventional
Study Design:
Allocation: Non-randomized controlled trial
Masking: Open (masking not used)
Control: Uncontrolled
Assignment: Single
Purpose: Treatment
Primary Sponsor: Punto Health Ltd
Condition:
Dementia and neurodegeneration
Nervous System Diseases
Intervention:
This is a multi-site feasibility study with an embedded health economics evaluation.
The study is designed to assess the feasibility of implementing PuntoCare within NHS primary and secondary care settings, alongsid...